BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 43 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $622,000 | -11.6% | 522,000 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $704,000 | 0.0% | 522,000 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $704,000 | -15.6% | 522,000 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $834,000 | -11.7% | 522,000 | -16.1% | 0.00% | -50.0% |
| Q1 2015 | $945,000 | -12.7% | 622,000 | -29.3% | 0.00% | 0.0% |
| Q4 2014 | $1,083,000 | – | 880,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonora Investment Management, LLC | 5,590,000 | $6,433,196,000 | 1.48% |
| SHENKMAN CAPITAL MANAGEMENT INC | 12,450,000 | $14,458,000 | 1.24% |
| LINDEN ADVISORS LP | 20,760,000 | $24,046,000 | 1.05% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,000,000 | $9,250,000 | 0.72% |
| Man Investments (CH) AG | 900,000 | $1,043,000 | 0.54% |
| Nicholas Investment Partners, LP | 6,600,000 | $7,631,000 | 0.53% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 28,035,000 | $32,497,000 | 0.50% |
| SSI INVESTMENT MANAGEMENT LLC | 2,067,000 | $2,389,000 | 0.23% |
| Calamos Advisors LLC | 23,382,000 | $27,088,000 | 0.19% |
| LOOMIS SAYLES & CO L P | 591,575 | $46,025,000 | 0.12% |